Thema
Journal Article
293
Research Support, Non-U.S. Gov't
127
Cost-effectiveness
33
Markov model
32
DNA
31
9007-49-2
28
Review
27
8L70Q75FXE
14
Adenosine Triphosphate
14
EC 3.6.1.-
14
EC 3.6.4.4
14
Kinesins
14
Medicine
13
R
13
Adenosine Triphosphatases
10
DNA-Binding Proteins
9
EC 3.6.4.12
9
Histones
9
RecQ Helicases
9
Atezolizumab
8
DNA Helicases
8
EC 3.6.4.-
8
Non-small cell lung cancer
8
Nucleosomes
8
Q
8
Science
8
Urothelial carcinoma
8
cost-effectiveness
8
615
7
61D2G4IYVH
7
Adenosine Diphosphate
7
Antineoplastic Agents
7
Astrocyte
7
Case Reports
7
NSCLC
7
Nivolumab
7
kinesin
7
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
6
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
6
AMP-Activated Protein Kinases
6
Antioxidants
6
Comparative Study
6
EC 2.7.10.1
6
EC 2.7.11.31
6
che
6
Antibodies, Monoclonal, Humanized
5
Breast cancer
5
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
5
Cisplatin
5
Daratumumab
5
mehr ...